CANSON CAPITAL PARTNERS ACTS AS LEAD FINANCIAL ADVISOR TO CAPVEST ON ITS ACQUISITION OF STADA AND CO-INVESTS VIA ITS MERCHANT BANKING ARM

STADA marks the sixth private equity transaction where Canson is financial advisor and co-investor

LONDON, Sept. 1, 2025 /PRNewswire/ -- Canson Capital Partners ("Canson") is delighted to announce that it has acted as Lead Financial Advisor to CapVest Partners LLP ("CapVest"), a leading international private equity investor, on its agreement to invest in STADA Arzneimittel AG ("STADA"). The transaction involves the acquisition of a majority stake in STADA from Bain Capital and Cinven, who will remain minority investors.

Founded in 1895, STADA is a leading pan-European pharmaceutical company with strong market positions across Consumer Health, Generics, and Specialty Medicines. STADA's products are sold in over 110 countries, with a primary focus on Europe, Eurasia, and Emerging Markets. The company operates with fully integrated capabilities across development, procurement, manufacturing, and commercialisation. In FY24, STADA generated revenues in excess of €4 billion.

As an exceptional healthcare investor with a proven value-creation playbook, CapVest is well positioned to accelerate STADA's next phase of growth by partnering with its management team to strengthen market leadership and drive expansion through innovation, in-licensing, and M&A.

This transaction further reinforces Canson's partnership approach to unlocking opportunities:

• Monitored STADA and its end markets closely for several years, maintaining strong relationships with its current private equity owners
• Partnered with Alan Main, a leading global expert in Consumer Health and former Head of Sanofi Consumer Health, who provided strategic insight and played a key role in the due diligence process  
• Teamed up with a highly experienced investor with deep sector knowledge and proven track record in driving transformational growth

The transaction reinforces Canson's expertise in healthcare and strengthens our distinctive position in Consumer Health, a focus initiated through our partnership with Alan Main and since expanded through involvement in numerous sector-defining transactions.

Schreibe Deinen Kommentar